Siemens Healthineers Focuses on Digital Transformation of Imaging and Therapy at RSNA 2019
|
By MedImaging International staff writers Posted on 02 Dec 2019 |

Illustration
Siemens Healthineers (Erlangen, Germany) highlighted products and solutions at this year’s RSNA focusing strongly on the digital transformation of imaging and therapy to improve patient care.
Siemens’ intelligent imaging technologies, digital health and connected digital interventional solutions enable fast and accurate diagnosis, informed decision-making along the patient journey and next-generation treatment delivery to help deliver better outcomes while increasing efficiency. At RSNA 2019, Siemens demonstrated how it is expanding precision medicine and transforming care delivery to help make the right decision at the right time for every patient – efficiently.
Siemens displayed its new Somatom X.cite premium single-source computed tomography (CT) scanner along with the new myExam Companion intelligent user interface concept. The Somatom X.cite CT scanner, which was recently cleared by the US Food and Drug Administration (FDA), has a large, 82 cm gantry bore and optional Moodlight feature, and includes the Patient Observation Camera. This new 2-D visualization camera allows the technologist to closely monitor the patient while he or she is inside the gantry for potentially fewer patient motion artifacts. The Somatom X.cite also includes Visual Patient Instruction, a new visual breath hold indicator on the gantry that guides the patient through the breath hold process with color-guided visual instructions. Together, these features create a holistic, patient-centric scanning experience.
The Somatom X.cite is the first CT scanner launching with the myExam Companion which enables technologists to utilize the full potential of the new CT scanner. The intuitive user interface of the myExam Companion guides the user through the exam workflow with precise questions about the patient. The myExam Companion combines available patient data such as gender and age with other user or machine-observable, patient-specific information – for example, a patient’s electrocardiogram (ECG) waveform for a cardiac study – to identify optimal acquisition and reconstruction techniques for each patient. Together, these innovations make the imaging process more efficient, compensating for differences in user experience levels and scan complexities on even the most complicated acquisitions, including coronary CT angiography (CTA) studies.
Other products featured by Siemens at RSNA 2019 were the ACUSON Redwood ultrasound system which delivers premium image quality, exceptional performance and smart workflow amidst tight budgets; the AIDAN intelligent scanner platform for PET/CT; the AI-RAD Companion Chest CT which automatically performs measurements and prepares results in the form of clinical images and reports; the AI-Pathway Companion that aims to be the next generation in clinical decision support systems; and the ARTIS icono which is transforming care delivery in image-guided therapy and is the future of minimally-invasive treatment.
At this year’s RSNA, Siemens also held comprehensive hands-on workshops in 3D breast ultrasound, 50° Wide-Angle Tomosynthesis, reading of Synthetic 2D images, and breast MRI.
Related Links:
Siemens Healthineers
Siemens’ intelligent imaging technologies, digital health and connected digital interventional solutions enable fast and accurate diagnosis, informed decision-making along the patient journey and next-generation treatment delivery to help deliver better outcomes while increasing efficiency. At RSNA 2019, Siemens demonstrated how it is expanding precision medicine and transforming care delivery to help make the right decision at the right time for every patient – efficiently.
Siemens displayed its new Somatom X.cite premium single-source computed tomography (CT) scanner along with the new myExam Companion intelligent user interface concept. The Somatom X.cite CT scanner, which was recently cleared by the US Food and Drug Administration (FDA), has a large, 82 cm gantry bore and optional Moodlight feature, and includes the Patient Observation Camera. This new 2-D visualization camera allows the technologist to closely monitor the patient while he or she is inside the gantry for potentially fewer patient motion artifacts. The Somatom X.cite also includes Visual Patient Instruction, a new visual breath hold indicator on the gantry that guides the patient through the breath hold process with color-guided visual instructions. Together, these features create a holistic, patient-centric scanning experience.
The Somatom X.cite is the first CT scanner launching with the myExam Companion which enables technologists to utilize the full potential of the new CT scanner. The intuitive user interface of the myExam Companion guides the user through the exam workflow with precise questions about the patient. The myExam Companion combines available patient data such as gender and age with other user or machine-observable, patient-specific information – for example, a patient’s electrocardiogram (ECG) waveform for a cardiac study – to identify optimal acquisition and reconstruction techniques for each patient. Together, these innovations make the imaging process more efficient, compensating for differences in user experience levels and scan complexities on even the most complicated acquisitions, including coronary CT angiography (CTA) studies.
Other products featured by Siemens at RSNA 2019 were the ACUSON Redwood ultrasound system which delivers premium image quality, exceptional performance and smart workflow amidst tight budgets; the AIDAN intelligent scanner platform for PET/CT; the AI-RAD Companion Chest CT which automatically performs measurements and prepares results in the form of clinical images and reports; the AI-Pathway Companion that aims to be the next generation in clinical decision support systems; and the ARTIS icono which is transforming care delivery in image-guided therapy and is the future of minimally-invasive treatment.
At this year’s RSNA, Siemens also held comprehensive hands-on workshops in 3D breast ultrasound, 50° Wide-Angle Tomosynthesis, reading of Synthetic 2D images, and breast MRI.
Related Links:
Siemens Healthineers
Latest RSNA 2019 News
- Carestream Introduces Three-Dimensional Extension of General Radiography Through Its Digital Tomosynthesis Functionality
- Lunit Demonstrates Latest Updated AI Solutions for Chest and Breast Radiology at RSNA 2019
- Bracco Diagnostics Unveils Contrast Media and Device Offerings at RSNA 2019
- Guerbet Showcases New Dose&Care and Other Digital Solutions with Diagnostic and Interventional Imaging Offerings
- Canon Introduces New Wireless Detectors and Digital PET/CT Scanner at RSNA 2019
- Siemens Healthineers Introduces SOMATOM On.site Mobile Head CT Scanner and AI-based MRI Assistants at RSNA
- Hologic Launches Unifi Workspace, Comprehensive Reading Solution for Breast Health Diagnostics
- Agfa Launches New Groundbreaking Digital Radiography Unit at RSNA 2019
- Fujifilm SonoSite Exhibits Complete Point-of-Care Ultrasound Portfolio at RSNA 2019
- Fujifilm Previews World's First Glass-Free Digital Radiography Detector at RSNA 2019 Image
- NVIDIA Showcases Latest AI-driven Medical Imaging Advancements at RSNA 2019
- Philips Healthcare Demonstrates How AI Breast Software Brings Intelligence and Automation to Breast Ultrasound
Channels
Radiography
view channel
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read more
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more








